XPC polymorphisms and lung cancer risk

International Journal of Cancer

Volumn 115, Issue 5, 2005, Pages 807-813

  Lee, Ga Young ^a   Jang, Jin Sung ^b   Lee, Sin Yeob ^a   Jeon, Hyo Sung ^a   Kim, Kyung Mee ^a   Choi, Jin Eun ^a   Park, Jung Min ^a   Chae, Myung Hwa ^a   Lee, Won Kee ^c   Kam, Sin ^b,c   Kim, In San ^b   Lee, Jae Tae ^a   Jung, Tae Hoon ^a   Park, Jae Yong ^a,b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Genetic susceptibility; Haplotype; Lung cancer; Polymorphism; XPC

Indexed keywords

GENE PRODUCT; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; BAYES THEOREM; CANCER RISK; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SMALL CELL CARCINOMA; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; XPC GENE;

AGED; CASE-CONTROL STUDIES; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TRANSGLUTAMINASES;

EID: 20144368167     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20900     Document Type: Article

References (34)

1. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000;18:2309-15.
2. Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promise and perils of individuals and population risk estimation? Mutat Res 1998;400:15-24.
3. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
4. Hoeijmakers JHJ. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74.
5. Wood EC, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001;291:1284-8.
6. Sancar A. DNA excision repair. Annu Rev Biochem 1996;65:43-81.
7. de Laat WL, Jaspers NGJ, Hoeijmakers JHJ. Molecular mechanism of nucleotide excision repair. Genes Dev 1999;13:768-85.
8. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996;56:4103-7.
9. Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1998;7:465-8.
10. Park JY, Park SH, Choi JE, Lee SY, Jeon H-S, Cha SI, Kim CH. Park J-H, Kam S, Park R-W, Kim I-S, Jung TH. Polymorphism of the DNA repair gene XPA and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002;11:993-7.
11. Park JY, Lee SY, Jeon H-S, Park SH, Bae NC, Lee EB, Cha SI, Park J-H, Kam S, Kim I-S, Jung TH. Lys751Gln polymorphism of the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer 2002;36:15-16.
12. Jeon H-S, Kim KM, Park SH, Lee SY, Choi JE, Lee GY, Kam S, Park RW, Kim I-S. Kim CH, Jung TH, Park JY. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003;24:1677-81.
13. Matutani C, Araki M, Sugawasa K, van der Spek PJ, Yamada A, Uchida A, Maekawa T, Bootsma D, Hoeijmakers JHJ, Hanaoka F. Identification and characterization of XPC binding domain of hHR23B. Mol Cell Biol 1997;17:6915-23.
14. Sugasawa K, Ng JMY, Masutani C, Iwai S, van der Spek PJ, Eker APM, Hannoka F, Bootsma D, Hoeijmakers JHJ. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 1998;2:223-32.
15. Yokoi M, Masutani C, Maekawa T, Sugasawa K, Ohkuma Y, Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor UH to damaged DNA. J Biol Chem 2000;275:9870-5.
16. -/- mice. Cancer Res 1999;59:771-5.
17. Friedberg EC, Bond JP, Burns DK, Cheo DL, Greenblatt MS, Meria LB, Nahari D, Reis AM. Defective nucleotide excision repair in Xpc mutant mice and its association with cancer predisposition. Mutat Res 2000;459:99-108.
18. Chavanne F, Broughton BC, Pietra D, Nardo T, Browitt A, Lehmann AR, Stefanini M. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res 2000;60:1974-82.
19. Khan SG, Metter EJ, Tarone RE, Bohr VA, Grossman L, Hedayati M, Bale SJ, Emmert S, Kracmer KH. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis 2000;21:1821-5.
20. Khan SG, Muniz-Medina V, Shahlavi T, Baker CC, Inui H, Ueda T. Emmert S, Schneider TD, Kraemer KH. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res 2002;30:3624-31.
21. Shen H, Sturgis EM, Khan SG, Qiao Y, Shahlavi T, Eicher SA, Xu Y, Wang X, Strom SS, Spitz MG, Kraemer KH, Wei Q. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res 2001;61:3321-5.
22. Lee C-T, Kang KH, Koh Y, Chang J, Chung HS, Park SK, Yoo K-Y, Song JS. Characteristics of lung cancer in Korea, 1997. Lung Cancer 2000;30:15-22.
23. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988;120:849-52.
24. Stephens M, Smith MJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
25. Sanyal S, Festa F, Sakano S, Zang Z, Steinneck G, Norming U, Wijkstrom H, Larsson P, Kumar R, Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004;25:729-34.
26. Gozukara EM, Khan SG, Metin A, Emmert S, Busch DB, Shahlavi T, Coleman DM, Miller M, Chinsomboon N, Stefanini M, Kraemer KH. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular evidence for a common ancestor. J Invest Dermatol 2001;117:197-204.
27. Grabe N. Alibaba2: context specific identification of transcription factor binding sites. In Silico Biol 2002;2:S1-1.
28. Qiao Y, Spitz MR, Shen H, Guo Z, Shete S, Hedayati M, Grossman L, Mohrenweiser H, Wei Q. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002;23:295-9.
29. Seker H, Butkiewicz D, Bowman ED, Rusin M, Hedayati M, Grossman L, Harris CC. Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD Asp/Asp genotype. Cancer Res 2001;61:7430-4.
30. Deutsch-Wenzel R, Brune H, Grimmer G, Dettbarn G, Misfeld J. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polyaromatic hydrocarbons. J Natl Cancer Inst 1983;71:539-44.
31. Hoffman D, Rivenson A, Murphys SE, Chung FL, Amin S, Hecht SS. Cigarette smoking and adenocarcinoma of the lung: the relevance of nicotine-derived nitrosamines. J Smoking Relat Disord 1993;4:165-90.
32. Gu J, Spitz MR, Yang F, Wu X. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis 1999;20:1465-9.
33. Liu G, Miller DP, Zhou W, Thurston SW, Fan R, Xu LL, Lynch TJ, Wain JC, Su L, Christiani DC. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung cancer. Cancer Res 2001;61:8718-22.
34. Park SH, Lee GY, Jeon H-S, Lee SJ, Kim KM, Jang SS, Kim CH, Lee WK, Kam S, Park R-W, Kim I-S, Jung TH, Park JY. -93G→A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer 2004;112:678-82.